Please login to the form below

Not currently logged in
Email:
Password:

ABPI names NHS partnership manager

Raj Tugnet will lead work to strengthen pharma/NHS collaboration in UK
ABPI Raj Tugnet

The Association of the British Pharmaceutical Industry (ABPI) has named Raj Tugnet as its NHS partnership manager.

Tugnet, who joins from Nicoventures, will be responsible for developing the relationship between the UK pharma industry and the public healthcare system – an increasing priority for the ABPI.

He replaces Kevin Blakemore who left the ABPI in October 2013 to join Boehringer Ingelheim as head of strategic national accounts.

Tugnet managed a specialist healthcare development team at Nicoventures, which markets nicotine products for use in smoking cessation.

His prior experience includes a management role at Allergan UK where he was responsible for NHS tenders in neurology.

Before this, he spent more than 11 years at Roche in the UK, during which time he helped create joint working projects with the NHS.

In his new role, he will manage the four ABPI regional partnership managers and lead ABPI activities in academic health science networks and medicines optimisation.

Tugnet said of his new responsibilities: “Driving improved productivity through organisational and functional change in order to deliver greater patient value and health outcomes is a top priority for the NHS, pharmaceutical industry and aligned support groups.

“I am extremely excited in the possibilities that can be realised by working with our member organisations, local and regional NHS bodies and patient advocacy groups to reduce health inequalities and ensure appropriate medicines and technologies are available to all eligible patients.”

11th December 2013

From: Sales, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics